Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01011 NT PHARMA
RT Nominal up0.400 +0.040 (+11.111%)
Shareholder's Disclosure of Interests
Disclosure of Interest   ｜   Fund Raising   ｜   Share Repurchase
Date No. of Shares Issued Issue Price Total Fund Raised Type % of Issued Shs Raising Method
(Reason)
17/06/2026847,565,892HKD 0.365HKD 309.362MShares89.312Consideration Issue
(Debt Repayment Consideration equivalent to approx RMB 266.69 mil; Loan Capitalisation)
28/04/2025274,751,679HKD 0.450HKD 123.638MShares40.749Consideration Issue
(Acquisition Acquisition of business in AI medical image in the PRC; Consideration equal to RMB 116 mil)
 
 1  
Remark: Information above for reference only;
  Real time quote last updated: 24/06/2026 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.